155 related articles for article (PubMed ID: 26903180)
1. Ocular changes induced by drugs commonly used in dermatology.
Turno-Kręcicka A; Grzybowski A; Misiuk-Hojło M; Patryn E; Czajor K; Nita M
Clin Dermatol; 2016; 34(2):129-37. PubMed ID: 26903180
[TBL] [Abstract][Full Text] [Related]
2. [The effect of drugs used in treatment of skin disorders on visual system].
Szostakiewicz-Grabek B; Juszkiewicz-Borowiec M; Krasowska D
Pol Merkur Lekarski; 2016 Apr; 40(238):269-72. PubMed ID: 27137831
[TBL] [Abstract][Full Text] [Related]
3. Ocular side effects of systemic therapy of cutaneous diseases.
Sugar J
Int Ophthalmol Clin; 1985; 25(1):173-83. PubMed ID: 3972487
[No Abstract] [Full Text] [Related]
4. Drug-induced ocular disorders.
Li J; Tripathi RC; Tripathi BJ
Drug Saf; 2008; 31(2):127-41. PubMed ID: 18217789
[TBL] [Abstract][Full Text] [Related]
5. Side effects of retinoid therapy on the quality of vision.
Bergler-Czop B; Bilewicz-Stebel M; Stańkowska A; Bilewicz-Wyrozumska T
Acta Pharm; 2016 Dec; 66(4):471-478. PubMed ID: 27749251
[TBL] [Abstract][Full Text] [Related]
6. [Adverse effects of some modern drugs on the visual apparatus].
Knobloch R
Cesk Oftalmol; 1971 Nov; 27(6):367-73. PubMed ID: 5138253
[TBL] [Abstract][Full Text] [Related]
7. Retinoids and the eye.
Gross EG; Helfgott MA
Dermatol Clin; 1992 Jul; 10(3):521-31. PubMed ID: 1617811
[TBL] [Abstract][Full Text] [Related]
8. Ocular effects of oral retinoids.
Lebowitz MA; Berson DS
J Am Acad Dermatol; 1988 Jul; 19(1 Pt 2):209-11. PubMed ID: 3045165
[TBL] [Abstract][Full Text] [Related]
9. The spectrum of oculocutaneous disease: Part II. Neoplastic and drug-related causes of oculocutaneous disease.
Day A; Abramson AK; Patel M; Warren RB; Menter MA
J Am Acad Dermatol; 2014 May; 70(5):821.e1-19. PubMed ID: 24742849
[TBL] [Abstract][Full Text] [Related]
10. Ocular toxicity of antimalarials in dermatology: a survey of current practice.
Cox NH; Paterson WD
Br J Dermatol; 1994 Dec; 131(6):878-82. PubMed ID: 7857843
[TBL] [Abstract][Full Text] [Related]
11. Optometric implications of systemic drug therapy.
Canon SH
J Am Optom Assoc; 1985 Nov; 56(11):843-4. PubMed ID: 4078206
[TBL] [Abstract][Full Text] [Related]
12. Mucocutaneous and systemic toxicity of retinoids: monitoring and management.
Shalita AR
Dermatologica; 1987; 175 Suppl 1():151-7. PubMed ID: 3319724
[TBL] [Abstract][Full Text] [Related]
13. Prevention and management of glucocorticoid-induced side effects: A comprehensive review: Ocular, cardiovascular, muscular, and psychiatric side effects and issues unique to pediatric patients.
Caplan A; Fett N; Rosenbach M; Werth VP; Micheletti RG
J Am Acad Dermatol; 2017 Feb; 76(2):201-207. PubMed ID: 28088991
[TBL] [Abstract][Full Text] [Related]
14. Drugs affecting the eye.
Taylor F
Aust Fam Physician; 1985 Aug; 14(8):744-5. PubMed ID: 2864912
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous and ocular ramifications of ultraviolet radiation.
Lerman S; Van Voorhees A
Dermatol Clin; 1992 Jul; 10(3):483-504. PubMed ID: 1617808
[TBL] [Abstract][Full Text] [Related]
16. Ocular toxicity of systemic medications: a case series.
To TQ; Townsend JC
Optometry; 2000 Jan; 71(1):29-39. PubMed ID: 10680416
[TBL] [Abstract][Full Text] [Related]
17. Antimalarials in dermatology: mechanism of action, indications, and side effects.
Rodriguez-Caruncho C; Bielsa Marsol I
Actas Dermosifiliogr; 2014 Apr; 105(3):243-52. PubMed ID: 24656224
[TBL] [Abstract][Full Text] [Related]
18. Ocular side effects of the retinoids.
Gold JA; Shupack JL; Nemec MA
Int J Dermatol; 1989 May; 28(4):218-25. PubMed ID: 2656551
[No Abstract] [Full Text] [Related]
19. Retinoids.
Roenigk HH
Cutis; 1987 Apr; 39(4):301-5. PubMed ID: 3472776
[TBL] [Abstract][Full Text] [Related]
20. [Eye diseases attributable to dermatologic therapy].
Casanovas J
Klin Monbl Augenheilkd; 1987 May; 190(5):403-5. PubMed ID: 3613442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
